Postmarketing Trials for Rare Diseases

被引:0
|
作者
Llera, Virginia A. [1 ]
Roldan, Emilio J. A. [1 ]
机构
[1] GEISER Fdn, RA-5500 Mendoza, Argentina
关键词
D O I
10.1126/science.337.6091.154-b
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:154 / 154
页数:1
相关论文
共 50 条
  • [21] Trends of Clinical Trials for Drug Development in Rare Diseases
    Sakate, Ryuichi
    Fukagawa, Akiko
    Takagaki, Yuri
    Okura, Hanayuki
    Matsuyama, Akifumi
    CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (03): : 199 - 208
  • [22] Clinical trials in rare diseases: A challenge for the near future
    Corcia, P.
    Couratier, P.
    REVUE NEUROLOGIQUE, 2023, 179 (08) : 805 - 806
  • [23] Be bold, be flexible over drug trials for rare diseases
    Aldhous, Peter
    NEW SCIENTIST, 2012, 213 (2851) : 16 - 16
  • [24] A Bayesian adaptive design for clinical trials in rare diseases
    Williamson, S. Faye
    Jacko, Peter
    Villar, Sofia S.
    Jaki, Thomas
    COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2017, 113 : 136 - 153
  • [26] Clinical trials and rare diseases - Trials of adequate size are possible with the right organisation
    Brocklehurst, P
    Elbourne, D
    Garcia, J
    McCandlish, R
    BRITISH MEDICAL JOURNAL, 1996, 312 (7035): : 910 - 910
  • [27] Differences between clinical trials and postmarketing use
    Martin, K
    Bégaud, B
    Latry, P
    Miremont-Salamé, G
    Fourrier, A
    Moore, N
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (01) : 86 - 92
  • [28] Rethinking Research Ethics: The Case of Postmarketing Trials
    London, Alex John
    Kimmelman, Jonathan
    Carlisle, Benjamin
    SCIENCE, 2012, 336 (6081) : 544 - 545
  • [29] Tolerability of sumatriptan: clinical trials and postmarketing experience
    Welch, KMA
    Feniuk, W
    Mansbach, H
    Scott, A
    CEPHALALGIA, 2001, 21 (08) : 855 - 856
  • [30] Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges
    Ursino, Moreno
    Stallard, Nigel
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (03) : 1 - 9